Non-Invasive Intracranial Pressure Monitoring Devices Market - 41% of Growth to Originate from North America| Evolving Opportunities with Compumedics Ltd. & Integra LifeSciences Corp. | Technavio

For more insights on the market share of various regions- Download a sample report in MINUTES

Read the 120-page report with TOC on "Non-Invasive Intracranial Pressure Monitoring Devices Market Analysis Report by Application (Traumatic brain injury, Intracerebral hemorrhage, Subarachnoid hemorrhage, Meningitis, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW)), and the Segment Forecasts,2022-2026". Gain competitive intelligence about market leaders. Track key industry opportunities, trends, and threats. Information on marketing, brand, strategy and market development, sales, and supply functions - https://www.technavio.com/report/report/non-invasive-intracranial-pressure-monitoring-devices-market-industry-analysis

Non-Invasive Intracranial Pressure Monitoring Devices Market - Vendor Analysis

The non-invasive intracranial pressure monitoring devices market is concentrated and the vendors are deploying growth strategies such as investing in the development of customized solutions to compete in the market. The non-invasive intracranial pressure monitoring devices market report also offers information on several market vendors, including Compumedics Ltd., Integra LifeSciences Corp., Johnson and Johnson, Medtronic Plc, Natus Medical Inc., Nihon Kohden Corp., RAUMEDIC AG, Sophysa, and Spiegelberg GmbH and Co. KG among others.

• Compumedics Ltd. - The company offers non-invasive intracranial pressure monitoring devices that include electrode arrays, ambulatory EEG monitoring, and cEEG for ICU. 

To know about all major vendor offerings - Download a sample now!

Non-Invasive Intracranial Pressure Monitoring Devices Market - Drivers & Challenges

The growing awareness of non-invasive ICP monitoring devices is one of the key drivers supporting the non-invasive intracranial pressure monitoring devices market growth. For instance, in North America, the United States Brain Injury Alliance, Brain Injury Association of Canada, and Brain Injury Association of America are a few organizations that are working toward raising awareness about the prevention and management of brain injuries. These organizations also promote the use of non-invasive ICP monitoring devices. The presence of such organizations and associations helps in increasing awareness regarding brain injuries and provides support to hospitals and medical centers. These efforts are expected to enhance the growth of the global non-invasive ICP monitoring devices market during the forecast period.

However, the availability and use of invasive ICP monitoring devices is the factor hindering the non-invasive intracranial pressure monitoring devices market growth. Advances in technology have expanded the use of invasive ICP monitoring devices in conjunction with other medical devices. For instance, Integra LifeSciences offers Camino Flex Ventricular Catheter in conjunction with the magnetic resonance imaging (MRI) scan under the 1.5 and 3 Tesla devices. Camino Flex ventricular catheter is used for ICP monitoring as well as for the management of CSF. All these developments have resulted in the increased adoption of invasive ICP monitoring devices. Thus, the availability of invasive ICP monitoring devices as a substitute will pose a threat to the market vendors. Such market challenges can negatively impact the growth of the global non-invasive ICP monitoring devices market during the forecast period.

To know about the other drivers & challenges - Download a sample now!

Non-Invasive Intracranial Pressure Monitoring Devices Market: Segmentation Analysis

Application Outlook (Revenue, USD mn, 2021-2026)

• Traumatic brain injury - size and forecast 2021-2026
• Intracerebral hemorrhage - size and forecast 2021-2026
• Subarachnoid hemorrhage - size and forecast 2021-2026
• Meningitis - size and forecast 2021-2026
• Others - size and forecast 2021-2026

Geography Outlook (Revenue, USD mn, 2021-2026)

• North America - size and forecast 2021-2026
• Europe - size and forecast 2021-2026
• Asia - size and forecast 2021-2026
• Rest of World (ROW) - size and forecast 2021-2026

To know  about the contribution of each segment - Grab an Exclusive Sample Report

Don't wait, Make a strategic approach & boost your business goals with our Non-Invasive Intracranial Pressure Monitoring Devices Market Forecast Report - Buy Now!

Related Reports:

• The incubators, inhalators, respirators, resuscitators, and other breathing devices market share is expected to reach an estimated value of USD 809.74 million by 2026 at an accelerating CAGR of 7.73%. Download a free sample now!
• The POC molecular diagnostics market size has the potential to grow by USD 1.31 billion by 2024, and the market's growth momentum will decelerate during the forecast period. Download a free sample now!

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Traumatic brain injury - Market size and forecast 2021-2026
• Exhibit 28: Chart on Traumatic brain injury - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Traumatic brain injury - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Traumatic brain injury - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Traumatic brain injury - Year-over-year growth 2021-2026 (%)

• 5.4 Intracerebral hemorrhage - Market size and forecast 2021-2026
• Exhibit 32: Chart on Intracerebral hemorrhage - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Intracerebral hemorrhage - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Intracerebral hemorrhage - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Intracerebral hemorrhage - Year-over-year growth 2021-2026 (%)

• 5.5 Subarachnoid hemorrhage - Market size and forecast 2021-2026
• Exhibit 36: Chart on Subarachnoid hemorrhage - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Subarachnoid hemorrhage - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Subarachnoid hemorrhage - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Subarachnoid hemorrhage - Year-over-year growth 2021-2026 (%)

• 5.6 Meningitis - Market size and forecast 2021-2026
• Exhibit 40: Chart on Meningitis - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Meningitis - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Meningitis - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Meningitis - Year-over-year growth 2021-2026 (%)

• 5.7 Others - Market size and forecast 2021-2026
• Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.8 Market opportunity by Application
• Exhibit 48: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 50: Chart on Market share by geography 2021-2026 (%)
• Exhibit 51: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 52: Chart on Geographic comparison
• Exhibit 53: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.10 China - Market size and forecast 2021-2026
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.11 Japan - Market size and forecast 2021-2026
• Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 90: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 91: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 92: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 93: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 94: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 95: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 96: Matrix on vendor position and classification

• 10.3 Compumedics Ltd.
• Exhibit 97: Compumedics Ltd. - Overview
• Exhibit 98: Compumedics Ltd. - Product / Service
• Exhibit 99: Compumedics Ltd. - Key offerings

• 10.4 Integra LifeSciences Corp.
• Exhibit 100: Integra LifeSciences Corp. - Overview
• Exhibit 101: Integra LifeSciences Corp. - Business segments
• Exhibit 102: Integra LifeSciences Corp. - Key news
• Exhibit 103: Integra LifeSciences Corp. - Key offerings
• Exhibit 104: Integra LifeSciences Corp. - Segment focus

• 10.5 Johnson and Johnson
• Exhibit 105: Johnson and Johnson - Overview
• Exhibit 106: Johnson and Johnson - Business segments
• Exhibit 107: Johnson and Johnson - Key news
• Exhibit 108: Johnson and Johnson - Key offerings
• Exhibit 109: Johnson and Johnson - Segment focus

• 10.6 Medtronic Plc
• Exhibit 110: Medtronic Plc - Overview
• Exhibit 111: Medtronic Plc - Business segments
• Exhibit 112: Medtronic Plc - Key news
• Exhibit 113: Medtronic Plc - Key offerings
• Exhibit 114: Medtronic Plc - Segment focus

• 10.7 Natus Medical Inc.
• Exhibit 115: Natus Medical Inc. - Overview
• Exhibit 116: Natus Medical Inc. - Product / Service
• Exhibit 117: Natus Medical Inc. - Key news
• Exhibit 118: Natus Medical Inc. - Key offerings

• 10.8 Nihon Kohden Corp.
• Exhibit 119: Nihon Kohden Corp. - Overview
• Exhibit 120: Nihon Kohden Corp. - Product / Service
• Exhibit 121: Nihon Kohden Corp. - Key offerings

• 10.9 RAUMEDIC AG
• Exhibit 122: RAUMEDIC AG - Overview
• Exhibit 123: RAUMEDIC AG - Product / Service
• Exhibit 124: RAUMEDIC AG - Key offerings

• 10.10 Sophysa
• Exhibit 125: Sophysa - Overview
• Exhibit 126: Sophysa - Product / Service
• Exhibit 127: Sophysa - Key offerings

• 10.11 Spiegelberg GmbH and Co. KG
• Exhibit 128: Spiegelberg GmbH and Co. KG - Overview
• Exhibit 129: Spiegelberg GmbH and Co. KG - Product / Service
• Exhibit 130: Spiegelberg GmbH and Co. KG - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 131: Inclusions checklist
• Exhibit 132: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 133: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 134: Research methodology
• Exhibit 135: Validation techniques employed for market sizing
• Exhibit 136: Information sources

• 11.5 List of abbreviations
• Exhibit 137: List of abbreviations

About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio